Morgan Stanley Institutional Fund, Inc. Advantage Portfolio Class I MPAIX

Medalist Rating as of | See Morgan Stanley Investment Hub
  • NAV / 1-Day Return 26.00  /  +0.15 %
  • Total Assets 232.1M
  • Adj. Expense Ratio
    0.850%
  • Expense Ratio 0.840%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Large Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 1M
  • Status Open
  • TTM Yield 0.03%
  • Turnover 61%

USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MPAIX

Will MPAIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

An audacious but adept investment team.

Principal Robby Greengold

Robby Greengold

Principal

Summary

Morgan Stanley Institutional Advantage is a high-octane strategy whose daring risk/reward profile rests on the strength of an accomplished investment team. The strategy includes Luxembourg-domiciled MS INVF US Advantage.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MPAIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 60.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cloudflare Inc

13.08 28M
Technology

Royalty Pharma PLC Class A

7.27 16M
Healthcare

Morgan Stanley InstlLqdty TrsSecs Instl

7.06 15M
Cash and Equivalents

Tesla Inc

6.92 15M
Consumer Cyclical

Shopify Inc Registered Shs -A- Subord Vtg

5.34 11M
Technology

AppLovin Corp Ordinary Shares - Class A

5.28 11M
Communication Services

Medline Inc Ordinary Shares - Class A

5.15 11M
Healthcare

Roblox Corp Ordinary Shares - Class A

4.61 10M
Communication Services

Roivant Sciences Ltd Ordinary Shares

4.60 10M
Healthcare

DoorDash Inc Ordinary Shares - Class A

4.35 9M
Consumer Cyclical

Sponsor Center